Research area
Epilepsy medication trials
If you want to know whether a study may be a fit, CNS Medication Trials can help you find out. Epilepsy research looks at investigational medications, devices, and monitoring tools for people who live with seizures.
Updated
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Epilepsy medication studies in numbers
- epilepsy medication studies recruiting in the U.S.
- 36
- states with a study site
- 32
- studies that accept healthy volunteers
- 4
Source: ClinicalTrials.gov. Data processed .
Find epilepsy medication studies by state
These states have the most studies recruiting right now.
Florida
15 studies recruiting.
Texas
14 studies recruiting.
California
13 studies recruiting.
North Carolina
11 studies recruiting.
Maryland
10 studies recruiting.
New Jersey
9 studies recruiting.
Epilepsy medication studies recruiting now
As of November 17, 2026, 36 epilepsy medication studies are recruiting participants in the United States, according to ClinicalTrials.gov. This site lists only studies that test a medication, as each study is coded in the registry. This is what they have in common.
What they test
- medications36
- other approaches4
- devices2
- biologics such as vaccines or antibodies1
A study can test more than one.
Main purpose
- treating a condition28
- prevention3
- basic science2
- device feasibility1
Phase
- Early Phase 13
- Phase 13
- Phase 1/24
- Phase 28
- Phase 2/32
- Phase 311
- Phase 45
Who runs them
- industry18
- university, hospital or other16
- government2
Who they enroll
- adults (18 to 64)28
- older adults (65 and over)20
- children (under 18)19
4 also accept healthy volunteers.
These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.
Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 36 studies.
Recently updated epilepsy medication studies
The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.
A Study to Evaluate the Safety and Efficacy of CBD-OS in Participants With DEE
- Phase 3
- Ages 1 and older
- All sexes
- Sponsor
- Jazz Pharmaceuticals
- Recruiting in
- Bethesda, MD · Honolulu, HI
- Registry record
- NCT07723976 · updated
Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits
- Phase 4
- Ages 18 and older
- All sexes
- Sponsor
- VA Office of Research and Development
- Recruiting in
- Boston, MA · Miami, FL · New York, NY · and 1 more U.S. location
- Registry record
- NCT04419272 · updated
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Rapport Therapeutics Inc.
- Recruiting in
- Asheville, NC · Atlanta, GA · Bethesda, MD · and 14 more U.S. locations
- Registry record
- NCT07563881 · updated
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Rapport Therapeutics Inc.
- Recruiting in
- Bentonville, AR · Chicago, IL · Colorado Springs, CO · and 9 more U.S. locations
- Registry record
- NCT07594119 · updated
A Study to Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment of Juvenile Myoclonic Epilepsy
- Phase 2/3
- Ages 10 and older
- All sexes
- Sponsor
- Jazz Pharmaceuticals
- Recruiting in
- Honolulu, HI · Savannah, GA · Tampa, FL · and 1 more U.S. location
- Registry record
- NCT07723963 · updated
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
- Phase 3
- Ages 4 to 55
- All sexes
- Sponsor
- SK Life Science, Inc.
- Recruiting in
- Baltimore, MD · Bethesda, MD · Durham, NC · and 4 more U.S. locations
- Registry record
- NCT05219617 · updated
Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in the United States on ClinicalTrials.gov.
What epilepsy studies look at
When you start looking at an epilepsy study through CNS Medication Trials, you will soon see that no two ask the same things of you. Your part depends on the one question that particular study was set up to answer. If you live with seizures, research in this area may involve a medication, a device, or a monitoring tool. Each of those is investigational.
That word has a plain meaning here. The effect of the thing under test, and the risks that come with it, are not yet fully understood. Finding those answers is the reason a study is run at all.
Who may be able to take part
Before you can join an epilepsy study you find through CNS Medication Trials, the study team will check you against that study's own entry rules. They do this when you come in for screening. Judging your own eligibility beforehand is not something you are asked to do.
No single set of rules applies everywhere. A team may look at the medications you take now, your age, your health history, and the way the condition affects you. In some studies, people without the condition are enrolled too. Read our guide to screening and eligibility.
What taking part usually involves
A first conversation
Nothing else happens until a coordinator has given you a general outline of the epilepsy study and you have had your questions answered.
Informed consent
The study team then puts everything in writing for you, with the known risks set out alongside the rest. Whether you agree is yours to decide.
Screening
Next comes screening. The study team asks about your health and carries out tests, and the results tell them whether this CNS medication trial suits you. Some people are screened and do not go on to take part.
Study visits
After joining, you come in for visits on planned dates. These visits are how the study team follows your health while you are in the CNS medication trial. Leaving is your choice, and you can make it at any point.
Questions about epilepsy medication studies
Do I need a diagnosis to join a study about epilepsy?
The study team will tell you what applies to you, because it varies by study. Some require a confirmed diagnosis. Others assess you as part of screening.
Would I have to change the care I receive now?
The study doctor will go through your current care with you, because some CNS medication trials let it continue and others do not. Changing any part of your care is never something to do alone. Before you decide about a trial, you can also discuss it with your own doctor.
Is there a cost to take part?
You will generally find that study visits, study tests, and the study medication come at no cost to participants. Find out more about costs.
Ask about epilepsy medication studies
You will hear back from a coordinator after you send a few details. An enquiry about epilepsy studies at CNS Medication Trials is only an enquiry, and it places you under no obligation.
Independent information
- Epilepsy and Seizures — National Institute of Neurological Disorders and Stroke (NIH)
- Clinical Trials — MedlinePlus (National Library of Medicine)
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)